develop devices in mind

People with symptoms think about their condition 24 hours a day because it impacts every aspect of their lives. They adopt behaviours to compensate for their condition surrounding the bladder. Vivally allows patients to perform physicianprescribed therapy in their own homes when it is convenient for them, and treatments are done in as little as 30 minutes, once per week.

Closed-loop technology provides several benefits.

Vivally calibrates therapy to the patient’s own EMG signal (an indicator of nerve activation), allowing the physician to establish a personalised therapeutic output range for each patient, and sensors built into the garment continuously provide objective confirmation that the target nerve is being activated during therapy. Proprietary algorithms automatically adjust output in response to patient movement, allowing wearers to move about freely during therapy and be confident that the nerve remains sufficiently stimulated. Ensuring consistent nerve activation means that only minimal stimulation is needed to achieve a positive therapeutic effect, which improves user comfort. Two multicentre clinical studies performed with Vivally delivered efficacy rates that rivalled implantable neuromodulation, and showed high patient satisfaction, good adherence to a therapy schedule, and improved quality of life.

Finally, the non-invasive profile of the Vivally wearable also means that neuromodulation therapy is now accessible to patients earlier in the care pathway.

To innovate is to imagine a better future for patients, and then build it. Even though young start-up companies like Avation Medical face many hurdles -financing, regulatory, reimbursement, technical, supply chain, and more – when the patient is top of mind, the focus remains on the outcome, and the goal can be realised.